Women's Reproductive Health Research (WRHR) Career Development Program (K12 Clinical Trial Optional) | RFA-HD-25-005 | NICHD | 7/19/2024 | 11/16/2024 | | |
Effect of HIV and Substance Use Comorbidity on the Placenta and Maternal Outcomes (R01 Clinical Trial Optional) | RFA-DA-25-021 | NIDA | 10/30/2023 | 11/16/2024 | | |
The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional) | RFA-OD-22-028 | ORWH | 10/13/2022 | 11/23/2024 | | |
Solutions to Enable Diagnosis and Treatment of Adverse Health Consequences of Non-Disordered Drug Use (R41/R42 - Clinical Trial Optional) | RFA-DA-25-049 | NIH-NIAID | 6/13/2024 | 12/3/2024 | | |
Solutions to Enable Diagnosis and Treatment of Adverse Health Consequences of Non-Disordered Drug Use (R43/R44 - Clinical Trial Optional) | RFA-DA-25-050 | NIH-NIAID | 6/13/2024 | 12/3/2024 | | |
Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional) | PAR-23-180 | NIH | 11/7/2023 | 12/8/2024 | | |
Pediatric HIV/AIDS Cohort Study (PHACS) (U19 Clinical Trial Not Allowed) | RFA-HD-25-003 | NICHD | 8/16/2024 | 12/12/2024 | | |
Partnership for National Maternal and Child Health (MCH) Leadership | HRSA-25-028 | HRSA | 10/3/2024 | 1/3/2025 | | |
Maternal and Child Health Public Health Catalyst Program | HRSA-25-025 | HRSA | 10/25/2024 | 1/23/2025 | | |
Centers of Excellence in Maternal and Child Health Education, Science, and Practice | HRSA-25-027 | HRSA | 10/28/2024 | 1/27/2025 | | |
Model Continuums of Care Initiative (MCCI) to Advance Health Equity and End Health Disparities Among Women and Girls in Racial/Ethnic Minority and Other Underserved Communities (U34 Clinical Trials Required) | RFA-AA-24-006 | NIH, NIAAA, NINR, NIMHD | 3/6/2024 | 2/20/2025 | | |
Notice of Special Interest (NOSI): Implementation Science to Advance Maternal Health and Maternal Health Equity for the IMPROVE initiative | NOT-HD-22-043 | NICHD | 9/22/2022 | 5/7/2025 | | |
Risk and Protective Factors of Family Health and Family Level Interventions (R01 - Clinical Trial Optional) | PAR-21-358 | NIMHD | 5/5/2022 | 5/8/2025 | | |
U.S.-South Africa Program for Collaborative Biomedical Research – Phase 3 (HIV/AIDS) (R01 Clinical Trial Optional) | RFA-AI-24-023 | NIAID | 9/17/2024 | 5/12/2025 | | |
Advancing Research to Understand Congenital Malformations (R01 Clinical Trial Not Allowed) | PAR-25-146 | HHS/NIH | 11/6/2024 | 9/7/2025 | | |
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) | NSF 23-614 | NSF and NIH | N/A | 10/3/2025 | | |
Archiving and Documenting Child Health and Human Development Data Sets (R03 Clinical Trial Not Allowed) | PAR-24-256 | NICHD | 7/12/2024 | 11/17/2025 | | |
Notice of Special Interest: Tools to Enhance the Study of Prenatal and Pediatric Hydrocephalus | NOT-NS-23-003 | NINDS | 5/20/2022 | 12/10/2025 | | |
Notice of Special Interest: Disease Mechanisms of Prenatal and Pediatric Hydrocephalus | NOT-NS-23-004 | NINDS | 5/20/2022 | 12/10/2025 | | |
Notice of Special Interest : Research on the Health of Women of Underrepresented, Underserved, and Underreported (U3) Populations (Admin Supp Clinical Trial Optional) | NOT-OD-24-179 | ORWH | 10/11/2024 | 1/23/2026 | | |
Advancing Learning Health Care Research in Outpatient Mental Health Treatment Settings (R34 Clinical Trial Optional) | PAR-24-118 | NIMH; NIDA | 5/16/2024 | 1/8/2026 | | |
Notice of Special Interest (NOSI): Maternal Health and the Dental, Oral, and Craniofacial Development of their Children | NOT-DE-23-005 | NIDCR | 8/2/2023 | 3/17/2026 | | |
Notice of Special Interest (NOSI): Administrative Supplements to Leverage Network Infrastructure to Advance Multisite Research for Women, Children, Pregnant and Lactating Individuals and/or Persons with Disabilities | NOT-HD-23-005 | NICHD, ORWH | 2/27/2023 | 4/1/2026 | | |
Multisite Clinical Research: Leveraging Network Infrastructure to Advance Research for Women, Children, Pregnant and Lactating Individuals, and Persons with Disabilities (U01 Clinical Trial Optional) | PAR-23-037 | NICHD | 11/28/2022 | 5/7/2026 | | |
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional) | PAR-23-130 | NICHD | 3/1/2023 | 5/8/2026 | | |
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional) | PAR-23-131 | NICHD | 3/1/2023 | 5/8/2026 | | |
Notice of Special Interest (NOSI): Small Business Initiatives for Innovative tools and Technologies for Improving Outcomes for Maternal Health | NOT-EB-23-005 | NIH | 9/5/2023 | 9/6/2026 | | |
Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-23-295 | NHGRI | 10/30/2023 | 11/17/2026 | | |
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional) | PAR-24-068 | NIAAA | 11/22/2023 | 11/17/2026 | | |
Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-23-293 | NHGRI | 10/30/2023 | 11/19/2026 | | |
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-23-294 | NHGRI | 10/30/2023 | 11/19/2026 | | |
Understanding the Impact of Healthcare System and Clinician Factors on Disparities in Maternal Morbidity and Mortality (R01 - Clinical Trial Optional) | PAR-24-059 | NIH | 1/5/2024 | 1/8/2027 | | |
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional) | PAR-24-067 | NIAAA | 11/22/2023 | 1/8/2027 | | |
Notice of Special Interest: Women’s Health Research | NOT-OD-24-079 | NIH | 5/6/2024 | 11/5/2027 | | |
Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional) | PAR-25-227 | HHS/NIH | 11/6/2024 | 1/7/2028 | | |
Notice of Special Interest (NOSI): Consequences of Prenatal Fentanyl Exposure | NOT-DA-26-003 | NIDA | 9/13/2024 | 9/8/2028 | | |
Research to Advance the Science of Primary Care (R01) | PA-24-205 | AHRQ | 4/3/2024 | 11/6/2029 | | |
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional) | PAR-21-098 | NIAAA | 12/11/2020 | MANY | | |
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional) | PAR-21-097 | NIAAA | 12/11/2020 | MANY | | |
Notice of Early Expiration of NOT-HD-22-043 "Notice of Special Interest ( NOSI ): Implementation Science to Advance Maternal Health and Maternal Health Equity for the IMPROVE Initiative" | NOT-HD-23-008 | NICHD | 3/28/2023 | n/a | | |
Notice of Special Interest (NOSI): Advancing Research on Early Pregnancy Loss | NOT-HD-22-026 | NICHD | 7/5/2022 | n/a | | |
Notice of Intent to Publish a Funding Opportunity Announcement for Limited Competition: Environmental influences on Child Health Outcomes (ECHO) Pregnancy and Pediatric Cohort Study Sites. Clinical Trial Not Allowed (UG3/UH3) | NOT-OD-22-174 | NICHD | 7/6/2022 | n/a | | |
Notice of Intent to Publish a Funding Opportunity Announcement for Open Competition: Environmental influences on Child Health Outcomes (ECHO) Pregnancy Cohort Study Sites. Clinical Trial Not Allowed (UG3/UH3) | NOT-OD-22-171 | NICHD | 7/6/2022 | n/a | | |
Notice of Training and REDCap Demonstration for the Implementation of NICHD's CDE Recommendations for COVID-19 Research in Pediatric, Pregnant, and Lactating Populations Published Through the NIEHS Disaster Research Response (DR2) Portal | NOT-HD-22-047 | NICHD | 10/5/2022 | n/a | | |
Notice of NINR Participation in NOT-EB-21-001 "Notice of Special Interest (NOSI): Small Business Initiatives for Innovative Diagnostic Technology for Improving Outcomes for Maternal Health" | NOT-NR-23-003 | NINR | 11/28/2022 | n/a | | |